INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2717, 28800, 'Selexipag', 'Food prolongs the gastrointestinal absorption of selexipag.  When taken with food, the time to peak concentration (Tmax) was delayed and peak plasma concentration (Cmax) was approximately 30% lower.', 'food', 'Minor', '', 'DDInter', 0, X'789c4dcbd10980300c05c055de042ea30ba434da606a4a89d66eaf1404bfeeeb6656bea5d0864c1d81e1b4f381269e607568a763358b13b09872a5202adebf20b954bb38a2a537fefa380fa732230a', NULL, X'789c5d8e410ac2401004bfd217414182e013045f20786ecd2459b23bb3ec0e24f9bd4b040f5eead455f4ddac472e164dc70a9f0423ab170bea523d2823f8aa56b20753d8802a51d6903976c0731285736e5c824f185aecbc473ca4064316ce789bbe45bd706f1c1f89eb090b2b7a89dca407b5ff2e73644dfc176e3f81b95d5d43a24bdc70bd1c106d91d27d00784f4819');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2718, 28801, 'Selexipag', 'Food prolongs the gastrointestinal absorption of selexipag.  When taken with food, the time to peak concentration (Tmax) was delayed and peak plasma concentration (Cmax) was approximately 30% lower.', 'food', 'Minor', '', 'DDInter', 0, X'789c4dcbd10980300c05c055de042ea30ba434da606a4a89d66eaf1404bfeeeb6656bea5d0864c1d81e1b4f381269e607568a763358b13b09872a5202adebf20b954bb38a2a537fefa380fa732230a', NULL, X'789c5d8e410ac2401004bfd217414182e013045f20786ecd2459b23bb3ec0e24f9bd4b040f5eead455f4ddac472e164dc70a9f0423ab170bea523d2823f8aa56b20753d8802a51d6903976c0731285736e5c824f185aecbc473ca4064316ce789bbe45bd706f1c1f89eb090b2b7a89dca407b5ff2e73644dfc176e3f81b95d5d43a24bdc70bd1c106d91d27d00784f4819');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2719, 28802, 'Selexipag', 'Food prolongs the gastrointestinal absorption of selexipag.  When taken with food, the time to peak concentration (Tmax) was delayed and peak plasma concentration (Cmax) was approximately 30% lower.', 'food', 'Minor', '', 'DDInter', 0, X'789c4dcbd10980300c05c055de042ea30ba434da606a4a89d66eaf1404bfeeeb6656bea5d0864c1d81e1b4f381269e607568a763358b13b09872a5202adebf20b954bb38a2a537fefa380fa732230a', NULL, X'789c5d8e410ac2401004bfd217414182e013045f20786ecd2459b23bb3ec0e24f9bd4b040f5eead455f4ddac472e164dc70a9f0423ab170bea523d2823f8aa56b20753d8802a51d6903976c0731285736e5c824f185aecbc473ca4064316ce789bbe45bd706f1c1f89eb090b2b7a89dca407b5ff2e73644dfc176e3f81b95d5d43a24bdc70bd1c106d91d27d00784f4819');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2720, 28803, 'Selexipag', 'Food prolongs the gastrointestinal absorption of selexipag.  When taken with food, the time to peak concentration (Tmax) was delayed and peak plasma concentration (Cmax) was approximately 30% lower.', 'food', 'Minor', '', 'DDInter', 0, X'789c4dcbd10980300c05c055de042ea30ba434da606a4a89d66eaf1404bfeeeb6656bea5d0864c1d81e1b4f381269e607568a763358b13b09872a5202adebf20b954bb38a2a537fefa380fa732230a', NULL, X'789c5d8e410ac2401004bfd217414182e013045f20786ecd2459b23bb3ec0e24f9bd4b040f5eead455f4ddac472e164dc70a9f0423ab170bea523d2823f8aa56b20753d8802a51d6903976c0731285736e5c824f185aecbc473ca4064316ce789bbe45bd706f1c1f89eb090b2b7a89dca407b5ff2e73644dfc176e3f81b95d5d43a24bdc70bd1c106d91d27d00784f4819');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2721, 28804, 'Selexipag', 'Food prolongs the gastrointestinal absorption of selexipag.  When taken with food, the time to peak concentration (Tmax) was delayed and peak plasma concentration (Cmax) was approximately 30% lower.', 'food', 'Minor', '', 'DDInter', 0, X'789c4dcbd10980300c05c055de042ea30ba434da606a4a89d66eaf1404bfeeeb6656bea5d0864c1d81e1b4f381269e607568a763358b13b09872a5202adebf20b954bb38a2a537fefa380fa732230a', NULL, X'789c5d8e410ac2401004bfd217414182e013045f20786ecd2459b23bb3ec0e24f9bd4b040f5eead455f4ddac472e164dc70a9f0423ab170bea523d2823f8aa56b20753d8802a51d6903976c0731285736e5c824f185aecbc473ca4064316ce789bbe45bd706f1c1f89eb090b2b7a89dca407b5ff2e73644dfc176e3f81b95d5d43a24bdc70bd1c106d91d27d00784f4819');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2722, 28805, 'Selexipag', 'Food prolongs the gastrointestinal absorption of selexipag.  When taken with food, the time to peak concentration (Tmax) was delayed and peak plasma concentration (Cmax) was approximately 30% lower.', 'food', 'Minor', '', 'DDInter', 0, X'789c4dcbd10980300c05c055de042ea30ba434da606a4a89d66eaf1404bfeeeb6656bea5d0864c1d81e1b4f381269e607568a763358b13b09872a5202adebf20b954bb38a2a537fefa380fa732230a', NULL, X'789c5d8e410ac2401004bfd217414182e013045f20786ecd2459b23bb3ec0e24f9bd4b040f5eead455f4ddac472e164dc70a9f0423ab170bea523d2823f8aa56b20753d8802a51d6903976c0731285736e5c824f185aecbc473ca4064316ce789bbe45bd706f1c1f89eb090b2b7a89dca407b5ff2e73644dfc176e3f81b95d5d43a24bdc70bd1c106d91d27d00784f4819');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2723, 6304, 'Selumetinib', 'Grapefruit juice may increase the plasma concentrations of selumetinib, which undergoes metabolism primarily by CYP450 3A4 and to a lesser extent by CYP450 2C19, 1A2, 2C9, 2E1 and 3A5, as well as glucuronidation by UGT1A1 and UGT1A3.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.  Inhibition of hepatic CYP450 3A4 may also contribute.', 'grapefruit juice', 'Major', '', 'DDInter', 0, X'789c4d8f6b0ac2400c84af320728829e44f0046937db46f6459255bcbddb82d87f6198f926f3e0d433bb1499615bed29606650c8433167e5805a40059c9b7f605e332d1bc89198cc71c508e9c8c4aa8caab81d8281e248839099d205b8930b17b75f09bdaa042cb5581f60191d3562556a1cb58b4fa71bcf2e0b4f3bdc7a6b89f301f26d3c31004e52ceeed055ca0a5726df9d788b6fb0ffcecb17daad5aa6', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2724, 6305, 'Selumetinib', 'Grapefruit juice may increase the plasma concentrations of selumetinib, which undergoes metabolism primarily by CYP450 3A4 and to a lesser extent by CYP450 2C19, 1A2, 2C9, 2E1 and 3A5, as well as glucuronidation by UGT1A1 and UGT1A3.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.  Inhibition of hepatic CYP450 3A4 may also contribute.', 'grapefruit juice', 'Major', '', 'DDInter', 0, X'789c4d8f6b0ac2400c84af320728829e44f0046937db46f6459255bcbddb82d87f6198f926f3e0d433bb1499615bed29606650c8433167e5805a40059c9b7f605e332d1bc89198cc71c508e9c8c4aa8caab81d8281e248839099d205b8930b17b75f09bdaa042cb5581f60191d3562556a1cb58b4fa71bcf2e0b4f3bdc7a6b89f301f26d3c31004e52ceeed055ca0a5726df9d788b6fb0ffcecb17daad5aa6', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2725, 24039, 'Simeprevir', 'Food significantly enhances the oral bioavailability of simeprevir, although the type of food does not seem to matter.  In healthy study subjects, administration of simeprevir after a high-fat, high-caloric (928 kcal) breakfast increased systemic exposure (AUC) by 61% and delayed absorption by 1 hour, while administration after a normal caloric (533 kcal) breakfast increased AUC by 69% and delayed absorption by 1.5 hours.', 'high-fat foods', 'Moderate', '', 'DDInter', 0, X'789c0dc4d10d80300805c055de00c6695c80069a9294d240ab8eaff771974346ee1018bd6ad4e1f147253de6521f07524d66c8ad816cbe3ba308884d87e69210c6a3aba1baf3f901a9e91dc1', NULL, X'789c7d90c14ec33010447f652e48452a954a55448f0809890fe00336c9265eea78237b53f0dfb30902090ebd586b7966e78d5f543b141992f4d252b258c129506ab9c00243334534a2742189d44814abd0de2d234f992f92b7a06841e721ac06ab132f827e59dca9af496a28cc234c319219e71df09a10783156149b3b3fe7e69d5b2bbeae1b2549b14c269afe86817af783106408773dd9f67b6a296a96169bd3fd23ce7ebb459399ce3d1583a4d6e7c25eb416e3d175fc3969993363f3f4f6ecda8a87fd0d28393247aa2ea5a6689e56027fddc31b7ad58f2091ff13fe3025cda3ffd62fcbf170b8c2e2c16beee96aeeeeb82697dd1778b7973e');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2726, 4799, 'Silodosin', 'The concurrent use of ethanol and alpha-1 adrenergic blockers may cause increased hypotensive effects.  Patients with aldehyde dehydrogenase deficiencies (primarily Asians) may be at a higher risk of this interaction.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458f5d72c3300884afb28fed4bee901bf40a58c21153021e81ecf1edab78daf489e167bf5dbe28852d03477354de597d0308ab8e68620f74a692e2065a933b381b992be68ae39a7f885529941c53b679842cca20addccecab84af7071bc5ab5ba54cc3727e229a0fad58e671dd25b8221db4bbd4b78b77a83c25918da54fd3a46fbe0177556c7fc9ff3907759b185a7c5c92df38a292277c9db86c1e398505eddc3cd9e2f5c221d950dccae87d22dff623f8f603df296bff', NULL, X'789c1d4e5b6e02410cbb8a3fcb47917a046ec0472f1066bc9b8825b34a42abbd3d031f9665c9af5f25daf0f68ca0179e498c052c151f1bc43b64db55be7f207d3a18ab35dcb6d1ee8cc4430e347987cc5b50921d7aeca3e8697f049785adf20c5ca56c0e24fead747676ead1890fc558e9333bd5626dda26125f7bd843c2b6039734f13c7de66e8414046aab321096f7f7e352cb79a218d2ca869f5f19d24fdd');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2727, 16723, 'Silodosin', 'The concurrent use of ethanol and alpha-1 adrenergic blockers may cause increased hypotensive effects.  Patients with aldehyde dehydrogenase deficiencies (primarily Asians) may be at a higher risk of this interaction.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458f5d72c3300884afb28fed4bee901bf40a58c21153021e81ecf1edab78daf489e167bf5dbe28852d03477354de597d0308ab8e68620f74a692e2065a933b381b992be68ae39a7f885529941c53b679842cca20addccecab84af7071bc5ab5ba54cc3727e229a0fad58e671dd25b8221db4bbd4b78b77a83c25918da54fd3a46fbe0177556c7fc9ff3907759b185a7c5c92df38a292277c9db86c1e398505eddc3cd9e2f5c221d950dccae87d22dff623f8f603df296bff', NULL, X'789c1d4e5b6e02410cbb8a3fcb47917a046ec0472f1066bc9b8825b34a42abbd3d031f9665c9af5f25daf0f68ca0179e498c052c151f1bc43b64db55be7f207d3a18ab35dcb6d1ee8cc4430e347987cc5b50921d7aeca3e8697f049785adf20c5ca56c0e24fead747676ead1890fc558e9333bd5626dda26125f7bd843c2b6039734f13c7de66e8414046aab321096f7f7e352cb79a218d2ca869f5f19d24fdd');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2728, 16724, 'Silodosin', 'The concurrent use of ethanol and alpha-1 adrenergic blockers may cause increased hypotensive effects.  Patients with aldehyde dehydrogenase deficiencies (primarily Asians) may be at a higher risk of this interaction.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458f5d72c3300884afb28fed4bee901bf40a58c21153021e81ecf1edab78daf489e167bf5dbe28852d03477354de597d0308ab8e68620f74a692e2065a933b381b992be68ae39a7f885529941c53b679842cca20addccecab84af7071bc5ab5ba54cc3727e229a0fad58e671dd25b8221db4bbd4b78b77a83c25918da54fd3a46fbe0177556c7fc9ff3907759b185a7c5c92df38a292277c9db86c1e398505eddc3cd9e2f5c221d950dccae87d22dff623f8f603df296bff', NULL, X'789c1d4e5b6e02410cbb8a3fcb47917a046ec0472f1066bc9b8825b34a42abbd3d031f9665c9af5f25daf0f68ca0179e498c052c151f1bc43b64db55be7f207d3a18ab35dcb6d1ee8cc4430e347987cc5b50921d7aeca3e8697f049785adf20c5ca56c0e24fead747676ead1890fc558e9333bd5626dda26125f7bd843c2b6039734f13c7de66e8414046aab321096f7f7e352cb79a218d2ca869f5f19d24fdd');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2729, 18172, 'Silodosin', 'The concurrent use of ethanol and alpha-1 adrenergic blockers may cause increased hypotensive effects.  Patients with aldehyde dehydrogenase deficiencies (primarily Asians) may be at a higher risk of this interaction.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458f5d72c3300884afb28fed4bee901bf40a58c21153021e81ecf1edab78daf489e167bf5dbe28852d03477354de597d0308ab8e68620f74a692e2065a933b381b992be68ae39a7f885529941c53b679842cca20addccecab84af7071bc5ab5ba54cc3727e229a0fad58e671dd25b8221db4bbd4b78b77a83c25918da54fd3a46fbe0177556c7fc9ff3907759b185a7c5c92df38a292277c9db86c1e398505eddc3cd9e2f5c221d950dccae87d22dff623f8f603df296bff', NULL, X'789c1d4e5b6e02410cbb8a3fcb47917a046ec0472f1066bc9b8825b34a42abbd3d031f9665c9af5f25daf0f68ca0179e498c052c151f1bc43b64db55be7f207d3a18ab35dcb6d1ee8cc4430e347987cc5b50921d7aeca3e8697f049785adf20c5ca56c0e24fead747676ead1890fc558e9333bd5626dda26125f7bd843c2b6039734f13c7de66e8414046aab321096f7f7e352cb79a218d2ca869f5f19d24fdd');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2730, 19150, 'Silodosin', 'The concurrent use of ethanol and alpha-1 adrenergic blockers may cause increased hypotensive effects.  Patients with aldehyde dehydrogenase deficiencies (primarily Asians) may be at a higher risk of this interaction.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458f5d72c3300884afb28fed4bee901bf40a58c21153021e81ecf1edab78daf489e167bf5dbe28852d03477354de597d0308ab8e68620f74a692e2065a933b381b992be68ae39a7f885529941c53b679842cca20addccecab84af7071bc5ab5ba54cc3727e229a0fad58e671dd25b8221db4bbd4b78b77a83c25918da54fd3a46fbe0177556c7fc9ff3907759b185a7c5c92df38a292277c9db86c1e398505eddc3cd9e2f5c221d950dccae87d22dff623f8f603df296bff', NULL, X'789c1d4e5b6e02410cbb8a3fcb47917a046ec0472f1066bc9b8825b34a42abbd3d031f9665c9af5f25daf0f68ca0179e498c052c151f1bc43b64db55be7f207d3a18ab35dcb6d1ee8cc4430e347987cc5b50921d7aeca3e8697f049785adf20c5ca56c0e24fead747676ead1890fc558e9333bd5626dda26125f7bd843c2b6039734f13c7de66e8414046aab321096f7f7e352cb79a218d2ca869f5f19d24fdd');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2731, 19151, 'Silodosin', 'The concurrent use of ethanol and alpha-1 adrenergic blockers may cause increased hypotensive effects.  Patients with aldehyde dehydrogenase deficiencies (primarily Asians) may be at a higher risk of this interaction.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458f5d72c3300884afb28fed4bee901bf40a58c21153021e81ecf1edab78daf489e167bf5dbe28852d03477354de597d0308ab8e68620f74a692e2065a933b381b992be68ae39a7f885529941c53b679842cca20addccecab84af7071bc5ab5ba54cc3727e229a0fad58e671dd25b8221db4bbd4b78b77a83c25918da54fd3a46fbe0177556c7fc9ff3907759b185a7c5c92df38a292277c9db86c1e398505eddc3cd9e2f5c221d950dccae87d22dff623f8f603df296bff', NULL, X'789c1d4e5b6e02410cbb8a3fcb47917a046ec0472f1066bc9b8825b34a42abbd3d031f9665c9af5f25daf0f68ca0179e498c052c151f1bc43b64db55be7f207d3a18ab35dcb6d1ee8cc4430e347987cc5b50921d7aeca3e8697f049785adf20c5ca56c0e24fead747676ead1890fc558e9333bd5626dda26125f7bd843c2b6039734f13c7de66e8414046aab321096f7f7e352cb79a218d2ca869f5f19d24fdd');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2732, 21814, 'Silodosin', 'The concurrent use of ethanol and alpha-1 adrenergic blockers may cause increased hypotensive effects.  Patients with aldehyde dehydrogenase deficiencies (primarily Asians) may be at a higher risk of this interaction.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458f5d72c3300884afb28fed4bee901bf40a58c21153021e81ecf1edab78daf489e167bf5dbe28852d03477354de597d0308ab8e68620f74a692e2065a933b381b992be68ae39a7f885529941c53b679842cca20addccecab84af7071bc5ab5ba54cc3727e229a0fad58e671dd25b8221db4bbd4b78b77a83c25918da54fd3a46fbe0177556c7fc9ff3907759b185a7c5c92df38a292277c9db86c1e398505eddc3cd9e2f5c221d950dccae87d22dff623f8f603df296bff', NULL, X'789c1d4e5b6e02410cbb8a3fcb47917a046ec0472f1066bc9b8825b34a42abbd3d031f9665c9af5f25daf0f68ca0179e498c052c151f1bc43b64db55be7f207d3a18ab35dcb6d1ee8cc4430e347987cc5b50921d7aeca3e8697f049785adf20c5ca56c0e24fead747676ead1890fc558e9333bd5626dda26125f7bd843c2b6039734f13c7de66e8414046aab321096f7f7e352cb79a218d2ca869f5f19d24fdd');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2733, 26093, 'Silodosin', 'The concurrent use of ethanol and alpha-1 adrenergic blockers may cause increased hypotensive effects.  Patients with aldehyde dehydrogenase deficiencies (primarily Asians) may be at a higher risk of this interaction.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458f5d72c3300884afb28fed4bee901bf40a58c21153021e81ecf1edab78daf489e167bf5dbe28852d03477354de597d0308ab8e68620f74a692e2065a933b381b992be68ae39a7f885529941c53b679842cca20addccecab84af7071bc5ab5ba54cc3727e229a0fad58e671dd25b8221db4bbd4b78b77a83c25918da54fd3a46fbe0177556c7fc9ff3907759b185a7c5c92df38a292277c9db86c1e398505eddc3cd9e2f5c221d950dccae87d22dff623f8f603df296bff', NULL, X'789c1d4e5b6e02410cbb8a3fcb47917a046ec0472f1066bc9b8825b34a42abbd3d031f9665c9af5f25daf0f68ca0179e498c052c151f1bc43b64db55be7f207d3a18ab35dcb6d1ee8cc4430e347987cc5b50921d7aeca3e8697f049785adf20c5ca56c0e24fead747676ead1890fc558e9333bd5626dda26125f7bd843c2b6039734f13c7de66e8414046aab321096f7f7e352cb79a218d2ca869f5f19d24fdd');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2734, 26964, 'Silodosin', 'The concurrent use of ethanol and alpha-1 adrenergic blockers may cause increased hypotensive effects.  Patients with aldehyde dehydrogenase deficiencies (primarily Asians) may be at a higher risk of this interaction.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458f5d72c3300884afb28fed4bee901bf40a58c21153021e81ecf1edab78daf489e167bf5dbe28852d03477354de597d0308ab8e68620f74a692e2065a933b381b992be68ae39a7f885529941c53b679842cca20addccecab84af7071bc5ab5ba54cc3727e229a0fad58e671dd25b8221db4bbd4b78b77a83c25918da54fd3a46fbe0177556c7fc9ff3907759b185a7c5c92df38a292277c9db86c1e398505eddc3cd9e2f5c221d950dccae87d22dff623f8f603df296bff', NULL, X'789c1d4e5b6e02410cbb8a3fcb47917a046ec0472f1066bc9b8825b34a42abbd3d031f9665c9af5f25daf0f68ca0179e498c052c151f1bc43b64db55be7f207d3a18ab35dcb6d1ee8cc4430e347987cc5b50921d7aeca3e8697f049785adf20c5ca56c0e24fead747676ead1890fc558e9333bd5626dda26125f7bd843c2b6039734f13c7de66e8414046aab321096f7f7e352cb79a218d2ca869f5f19d24fdd');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2735, 26965, 'Silodosin', 'The concurrent use of ethanol and alpha-1 adrenergic blockers may cause increased hypotensive effects.  Patients with aldehyde dehydrogenase deficiencies (primarily Asians) may be at a higher risk of this interaction.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458f5d72c3300884afb28fed4bee901bf40a58c21153021e81ecf1edab78daf489e167bf5dbe28852d03477354de597d0308ab8e68620f74a692e2065a933b381b992be68ae39a7f885529941c53b679842cca20addccecab84af7071bc5ab5ba54cc3727e229a0fad58e671dd25b8221db4bbd4b78b77a83c25918da54fd3a46fbe0177556c7fc9ff3907759b185a7c5c92df38a292277c9db86c1e398505eddc3cd9e2f5c221d950dccae87d22dff623f8f603df296bff', NULL, X'789c1d4e5b6e02410cbb8a3fcb47917a046ec0472f1066bc9b8825b34a42abbd3d031f9665c9af5f25daf0f68ca0179e498c052c151f1bc43b64db55be7f207d3a18ab35dcb6d1ee8cc4430e347987cc5b50921d7aeca3e8697f049785adf20c5ca56c0e24fead747676ead1890fc558e9333bd5626dda26125f7bd843c2b6039734f13c7de66e8414046aab321096f7f7e352cb79a218d2ca869f5f19d24fdd');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2736, 26976, 'Silodosin', 'The concurrent use of ethanol and alpha-1 adrenergic blockers may cause increased hypotensive effects.  Patients with aldehyde dehydrogenase deficiencies (primarily Asians) may be at a higher risk of this interaction.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458f5d72c3300884afb28fed4bee901bf40a58c21153021e81ecf1edab78daf489e167bf5dbe28852d03477354de597d0308ab8e68620f74a692e2065a933b381b992be68ae39a7f885529941c53b679842cca20addccecab84af7071bc5ab5ba54cc3727e229a0fad58e671dd25b8221db4bbd4b78b77a83c25918da54fd3a46fbe0177556c7fc9ff3907759b185a7c5c92df38a292277c9db86c1e398505eddc3cd9e2f5c221d950dccae87d22dff623f8f603df296bff', NULL, X'789c1d4e5b6e02410cbb8a3fcb47917a046ec0472f1066bc9b8825b34a42abbd3d031f9665c9af5f25daf0f68ca0179e498c052c151f1bc43b64db55be7f207d3a18ab35dcb6d1ee8cc4430e347987cc5b50921d7aeca3e8697f049785adf20c5ca56c0e24fead747676ead1890fc558e9333bd5626dda26125f7bd843c2b6039734f13c7de66e8414046aab321096f7f7e352cb79a218d2ca869f5f19d24fdd');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2737, 27803, 'Silodosin', 'The concurrent use of ethanol and alpha-1 adrenergic blockers may cause increased hypotensive effects.  Patients with aldehyde dehydrogenase deficiencies (primarily Asians) may be at a higher risk of this interaction.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458f5d72c3300884afb28fed4bee901bf40a58c21153021e81ecf1edab78daf489e167bf5dbe28852d03477354de597d0308ab8e68620f74a692e2065a933b381b992be68ae39a7f885529941c53b679842cca20addccecab84af7071bc5ab5ba54cc3727e229a0fad58e671dd25b8221db4bbd4b78b77a83c25918da54fd3a46fbe0177556c7fc9ff3907759b185a7c5c92df38a292277c9db86c1e398505eddc3cd9e2f5c221d950dccae87d22dff623f8f603df296bff', NULL, X'789c1d4e5b6e02410cbb8a3fcb47917a046ec0472f1066bc9b8825b34a42abbd3d031f9665c9af5f25daf0f68ca0179e498c052c151f1bc43b64db55be7f207d3a18ab35dcb6d1ee8cc4430e347987cc5b50921d7aeca3e8697f049785adf20c5ca56c0e24fead747676ead1890fc558e9333bd5626dda26125f7bd843c2b6039734f13c7de66e8414046aab321096f7f7e352cb79a218d2ca869f5f19d24fdd');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2738, 4799, 'Silodosin', 'Food may reduce the oral bioavailability of silodosin.  The effect of a moderate-fat, moderate-calorie meal on silodosin pharmacokinetics was variable and decreased silodosin maximum plasma concentration (Cmax) by approximately 18% to 43% and systemic exposure (AUC) by 4% to 49% across three different studies.  The maximum effect of food (i.e., coadministration with a high-fat, high-calorie meal) on the pharmacokinetics of silodosin was not evaluated.', 'high-fat foods', 'Moderate', '', 'DDInter', 0, X'789c15ccd10d80200c05c055de04cee20a953e4303d284165cdff87dc99d92c69181a8bebae2226c44ce55928a74a43422acbb7ad8c06b59217828fdd7495d85c84a4c8b06bf21ba3983e0fedfe303ee4923d3', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2739, 16723, 'Silodosin', 'Food may reduce the oral bioavailability of silodosin.  The effect of a moderate-fat, moderate-calorie meal on silodosin pharmacokinetics was variable and decreased silodosin maximum plasma concentration (Cmax) by approximately 18% to 43% and systemic exposure (AUC) by 4% to 49% across three different studies.  The maximum effect of food (i.e., coadministration with a high-fat, high-calorie meal) on the pharmacokinetics of silodosin was not evaluated.', 'high-fat foods', 'Moderate', '', 'DDInter', 0, X'789c15ccd10d80200c05c055de04cee20a953e4303d284165cdff87dc99d92c69181a8bebae2226c44ce55928a74a43422acbb7ad8c06b59217828fdd7495d85c84a4c8b06bf21ba3983e0fedfe303ee4923d3', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2740, 16724, 'Silodosin', 'Food may reduce the oral bioavailability of silodosin.  The effect of a moderate-fat, moderate-calorie meal on silodosin pharmacokinetics was variable and decreased silodosin maximum plasma concentration (Cmax) by approximately 18% to 43% and systemic exposure (AUC) by 4% to 49% across three different studies.  The maximum effect of food (i.e., coadministration with a high-fat, high-calorie meal) on the pharmacokinetics of silodosin was not evaluated.', 'high-fat foods', 'Moderate', '', 'DDInter', 0, X'789c15ccd10d80200c05c055de04cee20a953e4303d284165cdff87dc99d92c69181a8bebae2226c44ce55928a74a43422acbb7ad8c06b59217828fdd7495d85c84a4c8b06bf21ba3983e0fedfe303ee4923d3', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2741, 18172, 'Silodosin', 'Food may reduce the oral bioavailability of silodosin.  The effect of a moderate-fat, moderate-calorie meal on silodosin pharmacokinetics was variable and decreased silodosin maximum plasma concentration (Cmax) by approximately 18% to 43% and systemic exposure (AUC) by 4% to 49% across three different studies.  The maximum effect of food (i.e., coadministration with a high-fat, high-calorie meal) on the pharmacokinetics of silodosin was not evaluated.', 'high-fat foods', 'Moderate', '', 'DDInter', 0, X'789c15ccd10d80200c05c055de04cee20a953e4303d284165cdff87dc99d92c69181a8bebae2226c44ce55928a74a43422acbb7ad8c06b59217828fdd7495d85c84a4c8b06bf21ba3983e0fedfe303ee4923d3', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2742, 19150, 'Silodosin', 'Food may reduce the oral bioavailability of silodosin.  The effect of a moderate-fat, moderate-calorie meal on silodosin pharmacokinetics was variable and decreased silodosin maximum plasma concentration (Cmax) by approximately 18% to 43% and systemic exposure (AUC) by 4% to 49% across three different studies.  The maximum effect of food (i.e., coadministration with a high-fat, high-calorie meal) on the pharmacokinetics of silodosin was not evaluated.', 'high-fat foods', 'Moderate', '', 'DDInter', 0, X'789c15ccd10d80200c05c055de04cee20a953e4303d284165cdff87dc99d92c69181a8bebae2226c44ce55928a74a43422acbb7ad8c06b59217828fdd7495d85c84a4c8b06bf21ba3983e0fedfe303ee4923d3', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2743, 19151, 'Silodosin', 'Food may reduce the oral bioavailability of silodosin.  The effect of a moderate-fat, moderate-calorie meal on silodosin pharmacokinetics was variable and decreased silodosin maximum plasma concentration (Cmax) by approximately 18% to 43% and systemic exposure (AUC) by 4% to 49% across three different studies.  The maximum effect of food (i.e., coadministration with a high-fat, high-calorie meal) on the pharmacokinetics of silodosin was not evaluated.', 'high-fat foods', 'Moderate', '', 'DDInter', 0, X'789c15ccd10d80200c05c055de04cee20a953e4303d284165cdff87dc99d92c69181a8bebae2226c44ce55928a74a43422acbb7ad8c06b59217828fdd7495d85c84a4c8b06bf21ba3983e0fedfe303ee4923d3', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2744, 21814, 'Silodosin', 'Food may reduce the oral bioavailability of silodosin.  The effect of a moderate-fat, moderate-calorie meal on silodosin pharmacokinetics was variable and decreased silodosin maximum plasma concentration (Cmax) by approximately 18% to 43% and systemic exposure (AUC) by 4% to 49% across three different studies.  The maximum effect of food (i.e., coadministration with a high-fat, high-calorie meal) on the pharmacokinetics of silodosin was not evaluated.', 'high-fat foods', 'Moderate', '', 'DDInter', 0, X'789c15ccd10d80200c05c055de04cee20a953e4303d284165cdff87dc99d92c69181a8bebae2226c44ce55928a74a43422acbb7ad8c06b59217828fdd7495d85c84a4c8b06bf21ba3983e0fedfe303ee4923d3', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2745, 26093, 'Silodosin', 'Food may reduce the oral bioavailability of silodosin.  The effect of a moderate-fat, moderate-calorie meal on silodosin pharmacokinetics was variable and decreased silodosin maximum plasma concentration (Cmax) by approximately 18% to 43% and systemic exposure (AUC) by 4% to 49% across three different studies.  The maximum effect of food (i.e., coadministration with a high-fat, high-calorie meal) on the pharmacokinetics of silodosin was not evaluated.', 'high-fat foods', 'Moderate', '', 'DDInter', 0, X'789c15ccd10d80200c05c055de04cee20a953e4303d284165cdff87dc99d92c69181a8bebae2226c44ce55928a74a43422acbb7ad8c06b59217828fdd7495d85c84a4c8b06bf21ba3983e0fedfe303ee4923d3', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2746, 26964, 'Silodosin', 'Food may reduce the oral bioavailability of silodosin.  The effect of a moderate-fat, moderate-calorie meal on silodosin pharmacokinetics was variable and decreased silodosin maximum plasma concentration (Cmax) by approximately 18% to 43% and systemic exposure (AUC) by 4% to 49% across three different studies.  The maximum effect of food (i.e., coadministration with a high-fat, high-calorie meal) on the pharmacokinetics of silodosin was not evaluated.', 'high-fat foods', 'Moderate', '', 'DDInter', 0, X'789c15ccd10d80200c05c055de04cee20a953e4303d284165cdff87dc99d92c69181a8bebae2226c44ce55928a74a43422acbb7ad8c06b59217828fdd7495d85c84a4c8b06bf21ba3983e0fedfe303ee4923d3', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2747, 26965, 'Silodosin', 'Food may reduce the oral bioavailability of silodosin.  The effect of a moderate-fat, moderate-calorie meal on silodosin pharmacokinetics was variable and decreased silodosin maximum plasma concentration (Cmax) by approximately 18% to 43% and systemic exposure (AUC) by 4% to 49% across three different studies.  The maximum effect of food (i.e., coadministration with a high-fat, high-calorie meal) on the pharmacokinetics of silodosin was not evaluated.', 'high-fat foods', 'Moderate', '', 'DDInter', 0, X'789c15ccd10d80200c05c055de04cee20a953e4303d284165cdff87dc99d92c69181a8bebae2226c44ce55928a74a43422acbb7ad8c06b59217828fdd7495d85c84a4c8b06bf21ba3983e0fedfe303ee4923d3', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2748, 26976, 'Silodosin', 'Food may reduce the oral bioavailability of silodosin.  The effect of a moderate-fat, moderate-calorie meal on silodosin pharmacokinetics was variable and decreased silodosin maximum plasma concentration (Cmax) by approximately 18% to 43% and systemic exposure (AUC) by 4% to 49% across three different studies.  The maximum effect of food (i.e., coadministration with a high-fat, high-calorie meal) on the pharmacokinetics of silodosin was not evaluated.', 'high-fat foods', 'Moderate', '', 'DDInter', 0, X'789c15ccd10d80200c05c055de04cee20a953e4303d284165cdff87dc99d92c69181a8bebae2226c44ce55928a74a43422acbb7ad8c06b59217828fdd7495d85c84a4c8b06bf21ba3983e0fedfe303ee4923d3', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2749, 27803, 'Silodosin', 'Food may reduce the oral bioavailability of silodosin.  The effect of a moderate-fat, moderate-calorie meal on silodosin pharmacokinetics was variable and decreased silodosin maximum plasma concentration (Cmax) by approximately 18% to 43% and systemic exposure (AUC) by 4% to 49% across three different studies.  The maximum effect of food (i.e., coadministration with a high-fat, high-calorie meal) on the pharmacokinetics of silodosin was not evaluated.', 'high-fat foods', 'Moderate', '', 'DDInter', 0, X'789c15ccd10d80200c05c055de04cee20a953e4303d284165cdff87dc99d92c69181a8bebae2226c44ce55928a74a43422acbb7ad8c06b59217828fdd7495d85c84a4c8b06bf21ba3983e0fedfe303ee4923d3', NULL, X'789c6591d16ac3300c457fe5be1452e802637dd81e47615fb07d80622b8b986d05db699bbf9f92aea4b0371b5d5d5d1d7da87a449a91d94f8e510786660ae844e94c12a893207586f62812d46b91d4029fa6e3be6757970a21aae74c959f7aaa87ede72868164664b3d4b459601c284772fa2389abb8820b159c290b758141c9c3b3cb4c85fd4357a4abc429620c5422c169729caa8d12336f4e56dea39b41e398d5941621cc787edda12a8e2fbbd5b7cca5721407be8e5aa6cc68debf4e6bdff1267c33a1cb5a8ae1c8ccf0629b661b8452272f5cfe00dcd36c20fa0567232db7070b473e4a9272cf77913a18aa41be871ba6f5f58868bf305a4ef08fce23fe1555d20a3e53986c47dffe02241ca33a');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2750, 687, 'Simvastatin', 'Concomitant use of statin medication with substantial quantities of alcohol may increase the risk of hepatic injury.  Transient increases in serum transaminases have been reported with statin use and while these increases generally resolve or improve with continued therapy or a brief interruption in therapy, there have been rare postmarketing reports of fatal and non-fatal hepatic failure in patients taking statins.  Patients who consume substantial quantities of alcohol and/or have a history of liver disease may be at increased risk for hepatic injury.  Active liver disease or unexplained transaminase elevations are contraindications to statin use.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c4d8ed10dc2300c4457b909988515dcc4552c52bbc40e85ed71111ffdb34e7eefee4e21ace1f066b3572c8c62539d3b5784815e26153e170fd210ea78cef348ca612ba8176bd6219adcb688a6cf148744432291f9c655ca2f769056942e2a4548afa574d0e053188d53560693e78221fec06a038d770a0b7b27199fb32e1f9db1fff7dfbefa2e4bc6', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2751, 3084, 'Simvastatin', 'Concomitant use of statin medication with substantial quantities of alcohol may increase the risk of hepatic injury.  Transient increases in serum transaminases have been reported with statin use and while these increases generally resolve or improve with continued therapy or a brief interruption in therapy, there have been rare postmarketing reports of fatal and non-fatal hepatic failure in patients taking statins.  Patients who consume substantial quantities of alcohol and/or have a history of liver disease may be at increased risk for hepatic injury.  Active liver disease or unexplained transaminase elevations are contraindications to statin use.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c4d8ed10dc2300c4457b909988515dcc4552c52bbc40e85ed71111ffdb34e7eefee4e21ace1f066b3572c8c62539d3b5784815e26153e170fd210ea78cef348ca612ba8176bd6219adcb688a6cf148744432291f9c655ca2f769056942e2a4548afa574d0e053188d53560693e78221fec06a038d770a0b7b27199fb32e1f9db1fff7dfbefa2e4bc6', NULL, X'789c8d524172c33008fc0a0f68d33774fa811efa0162e38846162e4849fdfb821c4f3239f586a4655976f5216590992b960acd086402ab58b9c04c230f5e49812bd704d68e1630c60c3f2d8aca64d18079902419665c81cba0844e541381b29d03906871a2c11fbf9bae07802fc5624c3e73c79b5760a46d861a8f3873e9d7092f0447a2024a8b68a5f1266753199ab1f85de2dc87faf9ce79a2428a39afde6c929d4914785e54bcec3483f822a539abf72a2e6b20108eca34395125d5b674137cd80df2d20b7a94867e5cc4ea8c7a26273cddd4767f26acee59a82c525eb7d36ec9849c9b8666880bb7c4a0e23918b60dcdedfadc5fae4942b1b599fe91874f7cf36dba4c84c45645d70064be90c2c8d6938ad88e8eb887316ec94dd1fc1cddfb50bdfb89c281add0ef92914b58f9902050a64bff4606e15218ae0edb3f97af2b0f611efe007d34f5bc');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2752, 10481, 'Simvastatin', 'Concomitant use of statin medication with substantial quantities of alcohol may increase the risk of hepatic injury.  Transient increases in serum transaminases have been reported with statin use and while these increases generally resolve or improve with continued therapy or a brief interruption in therapy, there have been rare postmarketing reports of fatal and non-fatal hepatic failure in patients taking statins.  Patients who consume substantial quantities of alcohol and/or have a history of liver disease may be at increased risk for hepatic injury.  Active liver disease or unexplained transaminase elevations are contraindications to statin use.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c4d8ed10dc2300c4457b909988515dcc4552c52bbc40e85ed71111ffdb34e7eefee4e21ace1f066b3572c8c62539d3b5784815e26153e170fd210ea78cef348ca612ba8176bd6219adcb688a6cf148744432291f9c655ca2f769056942e2a4548afa574d0e053188d53560693e78221fec06a038d770a0b7b27199fb32e1f9db1fff7dfbefa2e4bc6', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2753, 10487, 'Simvastatin', 'Concomitant use of statin medication with substantial quantities of alcohol may increase the risk of hepatic injury.  Transient increases in serum transaminases have been reported with statin use and while these increases generally resolve or improve with continued therapy or a brief interruption in therapy, there have been rare postmarketing reports of fatal and non-fatal hepatic failure in patients taking statins.  Patients who consume substantial quantities of alcohol and/or have a history of liver disease may be at increased risk for hepatic injury.  Active liver disease or unexplained transaminase elevations are contraindications to statin use.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c4d8ed10dc2300c4457b909988515dcc4552c52bbc40e85ed71111ffdb34e7eefee4e21ace1f066b3572c8c62539d3b5784815e26153e170fd210ea78cef348ca612ba8176bd6219adcb688a6cf148744432291f9c655ca2f769056942e2a4548afa574d0e053188d53560693e78221fec06a038d770a0b7b27199fb32e1f9db1fff7dfbefa2e4bc6', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2754, 14073, 'Simvastatin', 'Concomitant use of statin medication with substantial quantities of alcohol may increase the risk of hepatic injury.  Transient increases in serum transaminases have been reported with statin use and while these increases generally resolve or improve with continued therapy or a brief interruption in therapy, there have been rare postmarketing reports of fatal and non-fatal hepatic failure in patients taking statins.  Patients who consume substantial quantities of alcohol and/or have a history of liver disease may be at increased risk for hepatic injury.  Active liver disease or unexplained transaminase elevations are contraindications to statin use.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c4d8ed10dc2300c4457b909988515dcc4552c52bbc40e85ed71111ffdb34e7eefee4e21ace1f066b3572c8c62539d3b5784815e26153e170fd210ea78cef348ca612ba8176bd6219adcb688a6cf148744432291f9c655ca2f769056942e2a4548afa574d0e053188d53560693e78221fec06a038d770a0b7b27199fb32e1f9db1fff7dfbefa2e4bc6', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2755, 14074, 'Simvastatin', 'Concomitant use of statin medication with substantial quantities of alcohol may increase the risk of hepatic injury.  Transient increases in serum transaminases have been reported with statin use and while these increases generally resolve or improve with continued therapy or a brief interruption in therapy, there have been rare postmarketing reports of fatal and non-fatal hepatic failure in patients taking statins.  Patients who consume substantial quantities of alcohol and/or have a history of liver disease may be at increased risk for hepatic injury.  Active liver disease or unexplained transaminase elevations are contraindications to statin use.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c4d8ed10dc2300c4457b909988515dcc4552c52bbc40e85ed71111ffdb34e7eefee4e21ace1f066b3572c8c62539d3b5784815e26153e170fd210ea78cef348ca612ba8176bd6219adcb688a6cf148744432291f9c655ca2f769056942e2a4548afa574d0e053188d53560693e78221fec06a038d770a0b7b27199fb32e1f9db1fff7dfbefa2e4bc6', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2756, 22079, 'Simvastatin', 'Concomitant use of statin medication with substantial quantities of alcohol may increase the risk of hepatic injury.  Transient increases in serum transaminases have been reported with statin use and while these increases generally resolve or improve with continued therapy or a brief interruption in therapy, there have been rare postmarketing reports of fatal and non-fatal hepatic failure in patients taking statins.  Patients who consume substantial quantities of alcohol and/or have a history of liver disease may be at increased risk for hepatic injury.  Active liver disease or unexplained transaminase elevations are contraindications to statin use.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c4d8ed10dc2300c4457b909988515dcc4552c52bbc40e85ed71111ffdb34e7eefee4e21ace1f066b3572c8c62539d3b5784815e26153e170fd210ea78cef348ca612ba8176bd6219adcb688a6cf148744432291f9c655ca2f769056942e2a4548afa574d0e053188d53560693e78221fec06a038d770a0b7b27199fb32e1f9db1fff7dfbefa2e4bc6', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2757, 22772, 'Simvastatin', 'Concomitant use of statin medication with substantial quantities of alcohol may increase the risk of hepatic injury.  Transient increases in serum transaminases have been reported with statin use and while these increases generally resolve or improve with continued therapy or a brief interruption in therapy, there have been rare postmarketing reports of fatal and non-fatal hepatic failure in patients taking statins.  Patients who consume substantial quantities of alcohol and/or have a history of liver disease may be at increased risk for hepatic injury.  Active liver disease or unexplained transaminase elevations are contraindications to statin use.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c4d8ed10dc2300c4457b909988515dcc4552c52bbc40e85ed71111ffdb34e7eefee4e21ace1f066b3572c8c62539d3b5784815e26153e170fd210ea78cef348ca612ba8176bd6219adcb688a6cf148744432291f9c655ca2f769056942e2a4548afa574d0e053188d53560693e78221fec06a038d770a0b7b27199fb32e1f9db1fff7dfbefa2e4bc6', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2758, 27011, 'Simvastatin', 'Concomitant use of statin medication with substantial quantities of alcohol may increase the risk of hepatic injury.  Transient increases in serum transaminases have been reported with statin use and while these increases generally resolve or improve with continued therapy or a brief interruption in therapy, there have been rare postmarketing reports of fatal and non-fatal hepatic failure in patients taking statins.  Patients who consume substantial quantities of alcohol and/or have a history of liver disease may be at increased risk for hepatic injury.  Active liver disease or unexplained transaminase elevations are contraindications to statin use.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c4d8ed10dc2300c4457b909988515dcc4552c52bbc40e85ed71111ffdb34e7eefee4e21ace1f066b3572c8c62539d3b5784815e26153e170fd210ea78cef348ca612ba8176bd6219adcb688a6cf148744432291f9c655ca2f769056942e2a4548afa574d0e053188d53560693e78221fec06a038d770a0b7b27199fb32e1f9db1fff7dfbefa2e4bc6', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2759, 27012, 'Simvastatin', 'Concomitant use of statin medication with substantial quantities of alcohol may increase the risk of hepatic injury.  Transient increases in serum transaminases have been reported with statin use and while these increases generally resolve or improve with continued therapy or a brief interruption in therapy, there have been rare postmarketing reports of fatal and non-fatal hepatic failure in patients taking statins.  Patients who consume substantial quantities of alcohol and/or have a history of liver disease may be at increased risk for hepatic injury.  Active liver disease or unexplained transaminase elevations are contraindications to statin use.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c4d8ed10dc2300c4457b909988515dcc4552c52bbc40e85ed71111ffdb34e7eefee4e21ace1f066b3572c8c62539d3b5784815e26153e170fd210ea78cef348ca612ba8176bd6219adcb688a6cf148744432291f9c655ca2f769056942e2a4548afa574d0e053188d53560693e78221fec06a038d770a0b7b27199fb32e1f9db1fff7dfbefa2e4bc6', NULL, X'789c8d524172c33008fc0a0f68d33774fa811efa0162e38846162e4849fdfb821c4f3239f586a4655976f5216590992b960acd086402ab58b9c04c230f5e49812bd704d68e1630c60c3f2d8aca64d18079902419665c81cba0844e541381b29d03906871a2c11fbf9bae07802fc5624c3e73c79b5760a46d861a8f3873e9d7092f0447a2024a8b68a5f1266753199ab1f85de2dc87faf9ce79a2428a39afde6c929d4914785e54bcec3483f822a539abf72a2e6b20108eca34395125d5b674137cd80df2d20b7a94867e5cc4ea8c7a26273cddd4767f26acee59a82c525eb7d36ec9849c9b8666880bb7c4a0e23918b60dcdedfadc5fae4942b1b599fe91874f7cf36dba4c84c45645d70064be90c2c8d6938ad88e8eb887316ec94dd1fc1cddfb50bdfb89c281add0ef92914b58f9902050a64bff4606e15218ae0edb3f97af2b0f611efe007d34f5bc');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2760, 27021, 'Simvastatin', 'Concomitant use of statin medication with substantial quantities of alcohol may increase the risk of hepatic injury.  Transient increases in serum transaminases have been reported with statin use and while these increases generally resolve or improve with continued therapy or a brief interruption in therapy, there have been rare postmarketing reports of fatal and non-fatal hepatic failure in patients taking statins.  Patients who consume substantial quantities of alcohol and/or have a history of liver disease may be at increased risk for hepatic injury.  Active liver disease or unexplained transaminase elevations are contraindications to statin use.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c4d8ed10dc2300c4457b909988515dcc4552c52bbc40e85ed71111ffdb34e7eefee4e21ace1f066b3572c8c62539d3b5784815e26153e170fd210ea78cef348ca612ba8176bd6219adcb688a6cf148744432291f9c655ca2f769056942e2a4548afa574d0e053188d53560693e78221fec06a038d770a0b7b27199fb32e1f9db1fff7dfbefa2e4bc6', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2761, 29985, 'Simvastatin', 'Concomitant use of statin medication with substantial quantities of alcohol may increase the risk of hepatic injury.  Transient increases in serum transaminases have been reported with statin use and while these increases generally resolve or improve with continued therapy or a brief interruption in therapy, there have been rare postmarketing reports of fatal and non-fatal hepatic failure in patients taking statins.  Patients who consume substantial quantities of alcohol and/or have a history of liver disease may be at increased risk for hepatic injury.  Active liver disease or unexplained transaminase elevations are contraindications to statin use.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c4d8ed10dc2300c4457b909988515dcc4552c52bbc40e85ed71111ffdb34e7eefee4e21ace1f066b3572c8c62539d3b5784815e26153e170fd210ea78cef348ca612ba8176bd6219adcb688a6cf148744432291f9c655ca2f769056942e2a4548afa574d0e053188d53560693e78221fec06a038d770a0b7b27199fb32e1f9db1fff7dfbefa2e4bc6', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2762, 29986, 'Simvastatin', 'Concomitant use of statin medication with substantial quantities of alcohol may increase the risk of hepatic injury.  Transient increases in serum transaminases have been reported with statin use and while these increases generally resolve or improve with continued therapy or a brief interruption in therapy, there have been rare postmarketing reports of fatal and non-fatal hepatic failure in patients taking statins.  Patients who consume substantial quantities of alcohol and/or have a history of liver disease may be at increased risk for hepatic injury.  Active liver disease or unexplained transaminase elevations are contraindications to statin use.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c4d8ed10dc2300c4457b909988515dcc4552c52bbc40e85ed71111ffdb34e7eefee4e21ace1f066b3572c8c62539d3b5784815e26153e170fd210ea78cef348ca612ba8176bd6219adcb688a6cf148744432291f9c655ca2f769056942e2a4548afa574d0e053188d53560693e78221fec06a038d770a0b7b27199fb32e1f9db1fff7dfbefa2e4bc6', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2763, 29987, 'Simvastatin', 'Concomitant use of statin medication with substantial quantities of alcohol may increase the risk of hepatic injury.  Transient increases in serum transaminases have been reported with statin use and while these increases generally resolve or improve with continued therapy or a brief interruption in therapy, there have been rare postmarketing reports of fatal and non-fatal hepatic failure in patients taking statins.  Patients who consume substantial quantities of alcohol and/or have a history of liver disease may be at increased risk for hepatic injury.  Active liver disease or unexplained transaminase elevations are contraindications to statin use.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c4d8ed10dc2300c4457b909988515dcc4552c52bbc40e85ed71111ffdb34e7eefee4e21ace1f066b3572c8c62539d3b5784815e26153e170fd210ea78cef348ca612ba8176bd6219adcb688a6cf148744432291f9c655ca2f769056942e2a4548afa574d0e053188d53560693e78221fec06a038d770a0b7b27199fb32e1f9db1fff7dfbefa2e4bc6', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2764, 687, 'Simvastatin', 'Coadministration with grapefruit juice may significantly increase the plasma concentrations of lovastatin and simvastatin and their active acid metabolites.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'grapefruit juice', 'Major', '', 'DDInter', 0, X'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', NULL, X'789c55504b6e033108bdcabb40a24a4d0f50e5025d74d3256333335436b60c93686e1f26aa5a75851ef03e706d94aba8980f72698abbf88a6550e7796ce2f8de24312aed3059546649a45e7688a6c1640c5f19bd9055426a9a587f940c6d466937320fac20cd2151ffe1e0ca0025971b47918cca4e532be26c67e0f3d01ead37e36394568aa4156261bfca24cfc46173fdfab8bcbde0f5fd72aa9c853cd66719e6a74e66bfa207559f8197cd71a75230ed483c9ca29f5aed6dd36c61c916771ccb7f9f383f00fcb46f2f');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2765, 3084, 'Simvastatin', 'Coadministration with grapefruit juice may significantly increase the plasma concentrations of lovastatin and simvastatin and their active acid metabolites.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'grapefruit juice', 'Major', '', 'DDInter', 0, X'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', NULL, X'789c55504b6e033108bdcabb40a24a4d0f50e5025d74d3256333335436b60c93686e1f26aa5a75851ef03e706d94aba8980f72698abbf88a6550e7796ce2f8de24312aed3059546649a45e7688a6c1640c5f19bd9055426a9a587f940c6d466937320fac20cd2151ffe1e0ca0025971b47918cca4e532be26c67e0f3d01ead37e36394568aa4156261bfca24cfc46173fdfab8bcbde0f5fd72aa9c853cd66719e6a74e66bfa207559f8197cd71a75230ed483c9ca29f5aed6dd36c61c916771ccb7f9f383f00fcb46f2f');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2766, 10481, 'Simvastatin', 'Coadministration with grapefruit juice may significantly increase the plasma concentrations of lovastatin and simvastatin and their active acid metabolites.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'grapefruit juice', 'Major', '', 'DDInter', 0, X'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', NULL, X'789c55504b6e033108bdcabb40a24a4d0f50e5025d74d3256333335436b60c93686e1f26aa5a75851ef03e706d94aba8980f72698abbf88a6550e7796ce2f8de24312aed3059546649a45e7688a6c1640c5f19bd9055426a9a587f940c6d466937320fac20cd2151ffe1e0ca0025971b47918cca4e532be26c67e0f3d01ead37e36394568aa4156261bfca24cfc46173fdfab8bcbde0f5fd72aa9c853cd66719e6a74e66bfa207559f8197cd71a75230ed483c9ca29f5aed6dd36c61c916771ccb7f9f383f00fcb46f2f');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2767, 10487, 'Simvastatin', 'Coadministration with grapefruit juice may significantly increase the plasma concentrations of lovastatin and simvastatin and their active acid metabolites.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'grapefruit juice', 'Major', '', 'DDInter', 0, X'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', NULL, X'789c55504b6e033108bdcabb40a24a4d0f50e5025d74d3256333335436b60c93686e1f26aa5a75851ef03e706d94aba8980f72698abbf88a6550e7796ce2f8de24312aed3059546649a45e7688a6c1640c5f19bd9055426a9a587f940c6d466937320fac20cd2151ffe1e0ca0025971b47918cca4e532be26c67e0f3d01ead37e36394568aa4156261bfca24cfc46173fdfab8bcbde0f5fd72aa9c853cd66719e6a74e66bfa207559f8197cd71a75230ed483c9ca29f5aed6dd36c61c916771ccb7f9f383f00fcb46f2f');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2768, 14073, 'Simvastatin', 'Coadministration with grapefruit juice may significantly increase the plasma concentrations of lovastatin and simvastatin and their active acid metabolites.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'grapefruit juice', 'Major', '', 'DDInter', 0, X'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', NULL, X'789c55504b6e033108bdcabb40a24a4d0f50e5025d74d3256333335436b60c93686e1f26aa5a75851ef03e706d94aba8980f72698abbf88a6550e7796ce2f8de24312aed3059546649a45e7688a6c1640c5f19bd9055426a9a587f940c6d466937320fac20cd2151ffe1e0ca0025971b47918cca4e532be26c67e0f3d01ead37e36394568aa4156261bfca24cfc46173fdfab8bcbde0f5fd72aa9c853cd66719e6a74e66bfa207559f8197cd71a75230ed483c9ca29f5aed6dd36c61c916771ccb7f9f383f00fcb46f2f');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2769, 14074, 'Simvastatin', 'Coadministration with grapefruit juice may significantly increase the plasma concentrations of lovastatin and simvastatin and their active acid metabolites.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'grapefruit juice', 'Major', '', 'DDInter', 0, X'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', NULL, X'789c55504b6e033108bdcabb40a24a4d0f50e5025d74d3256333335436b60c93686e1f26aa5a75851ef03e706d94aba8980f72698abbf88a6550e7796ce2f8de24312aed3059546649a45e7688a6c1640c5f19bd9055426a9a587f940c6d466937320fac20cd2151ffe1e0ca0025971b47918cca4e532be26c67e0f3d01ead37e36394568aa4156261bfca24cfc46173fdfab8bcbde0f5fd72aa9c853cd66719e6a74e66bfa207559f8197cd71a75230ed483c9ca29f5aed6dd36c61c916771ccb7f9f383f00fcb46f2f');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2770, 22079, 'Simvastatin', 'Coadministration with grapefruit juice may significantly increase the plasma concentrations of lovastatin and simvastatin and their active acid metabolites.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'grapefruit juice', 'Major', '', 'DDInter', 0, X'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', NULL, X'789c55504b6e033108bdcabb40a24a4d0f50e5025d74d3256333335436b60c93686e1f26aa5a75851ef03e706d94aba8980f72698abbf88a6550e7796ce2f8de24312aed3059546649a45e7688a6c1640c5f19bd9055426a9a587f940c6d466937320fac20cd2151ffe1e0ca0025971b47918cca4e532be26c67e0f3d01ead37e36394568aa4156261bfca24cfc46173fdfab8bcbde0f5fd72aa9c853cd66719e6a74e66bfa207559f8197cd71a75230ed483c9ca29f5aed6dd36c61c916771ccb7f9f383f00fcb46f2f');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2771, 22772, 'Simvastatin', 'Coadministration with grapefruit juice may significantly increase the plasma concentrations of lovastatin and simvastatin and their active acid metabolites.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'grapefruit juice', 'Major', '', 'DDInter', 0, X'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', NULL, X'789c55504b6e033108bdcabb40a24a4d0f50e5025d74d3256333335436b60c93686e1f26aa5a75851ef03e706d94aba8980f72698abbf88a6550e7796ce2f8de24312aed3059546649a45e7688a6c1640c5f19bd9055426a9a587f940c6d466937320fac20cd2151ffe1e0ca0025971b47918cca4e532be26c67e0f3d01ead37e36394568aa4156261bfca24cfc46173fdfab8bcbde0f5fd72aa9c853cd66719e6a74e66bfa207559f8197cd71a75230ed483c9ca29f5aed6dd36c61c916771ccb7f9f383f00fcb46f2f');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2772, 27011, 'Simvastatin', 'Coadministration with grapefruit juice may significantly increase the plasma concentrations of lovastatin and simvastatin and their active acid metabolites.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'grapefruit juice', 'Major', '', 'DDInter', 0, X'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', NULL, X'789c55504b6e033108bdcabb40a24a4d0f50e5025d74d3256333335436b60c93686e1f26aa5a75851ef03e706d94aba8980f72698abbf88a6550e7796ce2f8de24312aed3059546649a45e7688a6c1640c5f19bd9055426a9a587f940c6d466937320fac20cd2151ffe1e0ca0025971b47918cca4e532be26c67e0f3d01ead37e36394568aa4156261bfca24cfc46173fdfab8bcbde0f5fd72aa9c853cd66719e6a74e66bfa207559f8197cd71a75230ed483c9ca29f5aed6dd36c61c916771ccb7f9f383f00fcb46f2f');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2773, 27012, 'Simvastatin', 'Coadministration with grapefruit juice may significantly increase the plasma concentrations of lovastatin and simvastatin and their active acid metabolites.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'grapefruit juice', 'Major', '', 'DDInter', 0, X'789c6d53416e1b310cfc0a8f2d10a440910f142d7aeea11fa0b5b4cd5a2b6d49c9cee6f51dcaded8407ab26993c3e1cce8173795d29c4c92e859cb81da518c97952eda8e94eb99bda1a93c91eb7c2faa6164a255f00b9926a14f97a3a623a55a1a6bf187d1cfe4c7daf3443b219eceea186c95f85c758a7531e37d5e9ad642754f07ec97bd756dc4657a2cff746c7a26fa99fb9dca62fc50687ba862dcaabf37139bd02c8d7735eb1b68ec56aa713049795b67f13131f31a5417933da4d865b0ce4dac00e18c16c0789d059f13149b3a6707a56f39d3f251cddbde4dd4ff0ab158c5f179c5d8522d8e5ea917795d328444cbdc3d81c4c271529332818bb8870717e1537cc7e16c4d53cf6c00d23d714a40e5a2d72bf772167bc269c0748933bf607c623b41fd5cc3cb6ed8864b7e7fe03aa987ad5a3ada809d4ce22aa19316069a3a80ed2413564b9633b7e81b5713ef5c0ae2015fbd99945ebb93bc8aa5e0010ec09bd70ae98e6b000d3b2ef19f775f24055430553e940ac186d45e9fee62df788a0e23619a4128da43d441a0fb585eb9d1ceb80c8703f79662172807c257b2d3ac45c19347169b4624a01e66f348fad7f0eb85b0d17c28514bea86b3dad893b894da86bd11eec1f63bf701764bd5f07d84ea729402806da78407e3d11d4cf04f130e7ef7425ec12bb508db8fea112e4cf4b4bd9ae0bfa5fcea6ed6595bf47d785f1be4f5796d15721878be5135f9dbd5ae9643382de0c8d77d30eadd9ee77fbdbd93ef', NULL, X'789c55504b6e033108bdcabb40a24a4d0f50e5025d74d3256333335436b60c93686e1f26aa5a75851ef03e706d94aba8980f72698abbf88a6550e7796ce2f8de24312aed3059546649a45e7688a6c1640c5f19bd9055426a9a587f940c6d466937320fac20cd2151ffe1e0ca0025971b47918cca4e532be26c67e0f3d01ead37e36394568aa4156261bfca24cfc46173fdfab8bcbde0f5fd72aa9c853cd66719e6a74e66bfa207559f8197cd71a75230ed483c9ca29f5aed6dd36c61c916771ccb7f9f383f00fcb46f2f');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2774, 27021, 'Simvastatin', 'Coadministration with grapefruit juice may significantly increase the plasma concentrations of lovastatin and simvastatin and their active acid metabolites.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'grapefruit juice', 'Major', '', 'DDInter', 0, X'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', NULL, X'789c55504b6e033108bdcabb40a24a4d0f50e5025d74d3256333335436b60c93686e1f26aa5a75851ef03e706d94aba8980f72698abbf88a6550e7796ce2f8de24312aed3059546649a45e7688a6c1640c5f19bd9055426a9a587f940c6d466937320fac20cd2151ffe1e0ca0025971b47918cca4e532be26c67e0f3d01ead37e36394568aa4156261bfca24cfc46173fdfab8bcbde0f5fd72aa9c853cd66719e6a74e66bfa207559f8197cd71a75230ed483c9ca29f5aed6dd36c61c916771ccb7f9f383f00fcb46f2f');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2775, 29985, 'Simvastatin', 'Coadministration with grapefruit juice may significantly increase the plasma concentrations of lovastatin and simvastatin and their active acid metabolites.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'grapefruit juice', 'Major', '', 'DDInter', 0, X'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', NULL, X'789c55504b6e033108bdcabb40a24a4d0f50e5025d74d3256333335436b60c93686e1f26aa5a75851ef03e706d94aba8980f72698abbf88a6550e7796ce2f8de24312aed3059546649a45e7688a6c1640c5f19bd9055426a9a587f940c6d466937320fac20cd2151ffe1e0ca0025971b47918cca4e532be26c67e0f3d01ead37e36394568aa4156261bfca24cfc46173fdfab8bcbde0f5fd72aa9c853cd66719e6a74e66bfa207559f8197cd71a75230ed483c9ca29f5aed6dd36c61c916771ccb7f9f383f00fcb46f2f');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2776, 29986, 'Simvastatin', 'Coadministration with grapefruit juice may significantly increase the plasma concentrations of lovastatin and simvastatin and their active acid metabolites.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'grapefruit juice', 'Major', '', 'DDInter', 0, X'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', NULL, X'789c55504b6e033108bdcabb40a24a4d0f50e5025d74d3256333335436b60c93686e1f26aa5a75851ef03e706d94aba8980f72698abbf88a6550e7796ce2f8de24312aed3059546649a45e7688a6c1640c5f19bd9055426a9a587f940c6d466937320fac20cd2151ffe1e0ca0025971b47918cca4e532be26c67e0f3d01ead37e36394568aa4156261bfca24cfc46173fdfab8bcbde0f5fd72aa9c853cd66719e6a74e66bfa207559f8197cd71a75230ed483c9ca29f5aed6dd36c61c916771ccb7f9f383f00fcb46f2f');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2777, 29987, 'Simvastatin', 'Coadministration with grapefruit juice may significantly increase the plasma concentrations of lovastatin and simvastatin and their active acid metabolites.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'grapefruit juice', 'Major', '', 'DDInter', 0, X'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', NULL, X'789c55504b6e033108bdcabb40a24a4d0f50e5025d74d3256333335436b60c93686e1f26aa5a75851ef03e706d94aba8980f72698abbf88a6550e7796ce2f8de24312aed3059546649a45e7688a6c1640c5f19bd9055426a9a587f940c6d466937320fac20cd2151ffe1e0ca0025971b47918cca4e532be26c67e0f3d01ead37e36394568aa4156261bfca24cfc46173fdfab8bcbde0f5fd72aa9c853cd66719e6a74e66bfa207559f8197cd71a75230ed483c9ca29f5aed6dd36c61c916771ccb7f9f383f00fcb46f2f');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2778, 2173, 'Sitagliptin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2779, 3965, 'Sitagliptin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2780, 5531, 'Sitagliptin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c5590db4d04310c455b7101400f7c2051000d783277124b4e3cc4c92ed33d8ed022f88af23af7f8be6ab2624a952f4a3c1d54aed3b25e095598acaf3dfaef81343a7908da70bacb28b40b6f18f017a2f7bf3fabf9a0a3e373c65bbdc8529add699f5d5a264e738092359ff51c628dec20fe7109d2db0d2d083b82c1d5e64a4bdc48ed8e4e9b9aede433732797dce490b88c9027829f48c21a81f7128c51f0c09278d8e74062a7080c1c22fb221f56399535eb611a114b105fe8491c21f3118c8a54b889d740dc4c6f58ac229b3cdc378b2eb2ce180996d1e011c7d11154d7ba44d21a04fdb9234fe561fda21ec2510268d8bfe25fbe0143e09936');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2781, 6706, 'Sitagliptin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2782, 8020, 'Sitagliptin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2783, 19852, 'Sitagliptin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2784, 21130, 'Sitagliptin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c65914b6ec3300c44af32cb160802a440975df406bd822c31111b9a34243aae7bfa4a8e51f4b311040c86f3867c0bcea45eb1b067240e033955d46cb324849b714234adf3c87a419068d9047c8667e28241cc122e3247ab04ae50732c24d24d5e4c84d2015676c78a1c6e84bc4e54bcf045d64885138d1c0e509a8b4dc1f3ba39a6a0b150c373ae47e0ed17e89f887fe0c223fbcef80dad1eae043798125261bd22059615e716b7d8488aa009bed85dad3fe42e3e9c76d70b9e619f8d44e980d353ff0f4465c33e1d372d7175ded0eac485bd3eb6fc4efc3e6b7436bdf7b813aa953148cb68cf24415bddd71d7aefd3d73ad07e8936d43a2a689c7c45751b43cc3dfcdcb6614bbf147d50895ce9f8057ecaaedb', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2785, 21131, 'Sitagliptin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2786, 21135, 'Sitagliptin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2787, 21141, 'Sitagliptin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2788, 33401, 'Sitagliptin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c65914b6ec3300c44af32cb160802a440975df406bd822c31111b9a34243aae7bfa4a8e51f4b311040c86f3867c0bcea45eb1b067240e033955d46cb324849b714234adf3c87a419068d9047c8667e28241cc122e3247ab04ae50732c24d24d5e4c84d2015676c78a1c6e84bc4e54bcf045d64885138d1c0e509a8b4dc1f3ba39a6a0b150c373ae47e0ed17e89f887fe0c223fbcef80dad1eae043798125261bd22059615e716b7d8488aa009bed85dad3fe42e3e9c76d70b9e619f8d44e980d353ff0f4465c33e1d372d7175ded0eac485bd3eb6fc4efc3e6b7436bdf7b813aa953148cb68cf24415bddd71d7aefd3d73ad07e8936d43a2a689c7c45751b43cc3dfcdcb6614bbf147d50895ce9f8057ecaaedb', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2789, 84, 'Semaglutide', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2790, 271, 'Semaglutide', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2791, 6996, 'Semaglutide', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c65914b6ec3300c44af32cb160802a440975df406bd822c31111b9a34243aae7bfa4a8e51f4b311040c86f3867c0bcea45eb1b067240e033955d46cb324849b714234adf3c87a419068d9047c8667e28241cc122e3247ab04ae50732c24d24d5e4c84d2015676c78a1c6e84bc4e54bcf045d64885138d1c0e509a8b4dc1f3ba39a6a0b150c373ae47e0ed17e89f887fe0c223fbcef80dad1eae043798125261bd22059615e716b7d8488aa009bed85dad3fe42e3e9c76d70b9e619f8d44e980d353ff0f4465c33e1d372d7175ded0eac485bd3eb6fc4efc3e6b7436bdf7b813aa953148cb68cf24415bddd71d7aefd3d73ad07e8936d43a2a689c7c45751b43cc3dfcdcb6614bbf147d50895ce9f8057ecaaedb', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2792, 7537, 'Semaglutide', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2793, 7545, 'Semaglutide', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2794, 9298, 'Semaglutide', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2795, 9812, 'Semaglutide', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2796, 13327, 'Semaglutide', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2797, 13583, 'Semaglutide', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2798, 15697, 'Semaglutide', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2799, 15698, 'Semaglutide', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2800, 25708, 'Sirolimus', 'Consumption of food can decrease the rate and extent of gastrointestinal absorption of sirolimus.   Also, the consumption of grapefruit juice may result in increased sirolimus trough concentrations.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'789c4d90415205310844afd227f8b770efc20bf027cc0c9ac01490516f2f7161b90995d04dbff0f275b167c079b331581bf2a4ac4302cde7812723e983152c79b2a39a9d2912a68cd3a6e37231471a9852f4405d36d39048d6ecdff82ce37a5cd56662376b4b4eb749c34d2ee52b034411e2d665ccc0b32f59e79b7b3c80b7933148e74e5b4e2f8e3fe0001d245a443356fce174f1ee5312ef5336ae3c47933e57086cff97d12c780d7f2d80620d4401f6b6fe3c4c25cdb9fddab72e2a1b75502da8d3d39caaf90dbea5b156468da59ebcf432c6548b795dce11a409de77de321e3ff6d188aa', NULL, X'789c55ce510ac2400c45d1adbc0548f720ae24cea46d649a942403ba7ba70a16219fe1bc7b338dbeed29a6b019b359452145e5e24cc1c895e1940cd20a7e266b1e8f0b45ba8926478a5203ddc3fce784b835d97a4c00ae2decf281caffdae2b4f3ec5d128f2e85b1d10bced15b4274dcb7a19e1cc6685fd6032aa364840d2aa637ae554a6a');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2803, 1426, 'Sotalol', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2804, 27312, 'Sotalol', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2805, 27304, 'Sorafenib', 'Food may reduce the oral absorption and bioavailability of sorafenib.  According to the product labeling, sorafenib bioavailability was reduced by 29% when administered with a high-fat meal compared to administration in the fasted state.  When given with a moderate-fat meal, bioavailability was similar to that in the fasted state.', 'high-fat foods', 'Moderate', '', 'DDInter', 0, X'789c1d8cc10dc2400c045bd90210d5d0808fec81c5c58e6c47503e86df6a46b337072dcf2076f9e82e0b621bee6ea959b482c78f8df4384add2ee82593a603f9f4736d1844c98b06292c4a766344bb6835bdaf3d506fffa384cc6280526a8feb17d7322efe', NULL, X'789c6d8fb112c2300c437f450b1b30b031b2f00bcc6ee336be6be25e62e8f5ef714b8101960c96f4a45c550312cd281cee2dc322430b0da0a66a194d34837240234a0f92811a19c4666807d7a9e32ccd11b8b4ad9620b987e9ca188b3acfe0011efcbeffda7f5813d5adde7b669cce3b4c91bd3724c9528d5dc424164188d2c7434786c43eb2d534d2a27aebdb5d681d2d79ddd191e703aa91b1efbc2ddc5e1efe6ec0a4813dc21fe8feefbe2ac90fe5f53d77fec33f01ff5b7905');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2806, 27305, 'Sorafenib', 'Food may reduce the oral absorption and bioavailability of sorafenib.  According to the product labeling, sorafenib bioavailability was reduced by 29% when administered with a high-fat meal compared to administration in the fasted state.  When given with a moderate-fat meal, bioavailability was similar to that in the fasted state.', 'high-fat foods', 'Moderate', '', 'DDInter', 0, X'789c1d8cc10dc2400c045bd90210d5d0808fec81c5c58e6c47503e86df6a46b337072dcf2076f9e82e0b621bee6ea959b482c78f8df4384add2ee82593a603f9f4736d1844c98b06292c4a766344bb6835bdaf3d506fffa384cc6280526a8feb17d7322efe', NULL, X'789c6d8fb112c2300c437f450b1b30b031b2f00bcc6ee336be6be25e62e8f5ef714b8101960c96f4a45c550312cd281cee2dc322430b0da0a66a194d34837240234a0f92811a19c4666807d7a9e32ccd11b8b4ad9620b987e9ca188b3acfe0011efcbeffda7f5813d5adde7b669cce3b4c91bd3724c9528d5dc424164188d2c7434786c43eb2d534d2a27aebdb5d681d2d79ddd191e703aa91b1efbc2ddc5e1efe6ec0a4813dc21fe8feefbe2ac90fe5f53d77fec33f01ff5b7905');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2807, 266, 'Spironolactone', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c55504b72c33008bd0acb76c6f125b26e373d019148c454161a81d3e8f645b217ed8e81f7789f0f2c1daaf690c41235acb41b07c012e1faf975c160fc24c007155378a3f5b12e7e7cb1e4ee385d4029e2c0f8987a2d726cb11847aa8d547d3c17a7cc044865e1380e394892bcc0b66bc8048d32be06e71de895f8c636fe8a51d1e184ee770ae32169a5c0987387b8372e0fe0c2c6ee450ac81d8e347d2689a2ced480799e5780ab60dc9ca0d60ec60f5b9a265d8cdaa9a6933d8bf967e2a8637145a8d83cd09eb1c1135522bb84b48388b926bcdcb2846f6a0edfb07b3cddb30d26c6c8f62712b80bc74a8459dbdee8506f96440d9575fd05d6c1a145');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2808, 268, 'Spironolactone', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2809, 10788, 'Spironolactone', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2810, 10789, 'Spironolactone', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2811, 10816, 'Spironolactone', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2812, 10817, 'Spironolactone', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2813, 10818, 'Spironolactone', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2814, 25078, 'Spironolactone', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c3d90eb6d043108845ba180d335910622a502d6b06b24afb10c5ec5577df09e2e3f79cc37035f385cb402568254d4184eade2daa51eb06b07e28b8bb693ab83ee906753e76a4b230648971813d0b80549914ea962def1c686c23307158f00d813e047cfa886e7b0706183ce49cfc013e0a5420b832569d60252a1056729d71acbb5a6179a929418acd5ea1299b8dfa12e06eae3583edf1fa1651d8560e3ffb0ae6f2be8623763eba37999b0773d01c1c46f765c1faee3dcd6ed4da3fdf95410aabaec735d271d5a9e2649307e721f3c817f2353044891485e2fa96cf68022478e3112d3bb61b3266dfc08aff888399ad82ac031e599b093e0f30fc2489eac', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2815, 25079, 'Spironolactone', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2816, 25080, 'Spironolactone', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2817, 25081, 'Spironolactone', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2827, 5365, 'Sucralfate', 'The administration of sucralfate with enteral nutrition may result in precipitation and the formation of bezoars that may obstruct feeding tubes.  The proposed mechanism is the formation of an insoluble aluminum-protein complex between the aluminum in the sucralfate and the protein in the enteral feeding.  In addition, sucralfate may not become activated due to the alkaline pH of enteral nutrition products.', 'food', 'Moderate', '', 'DDInter', 0, X'789c158cc10dc2400c045bd9025024e8801f7f2a70924d72d29d7db21d44bae7f8ce8ce66d8de0b7d333e05cac35ea8a6017972cba230f22cec5a56e92c46ac1c0e6d6404d0e8c8d5c4719982f48a2522271c761a74fc0b38e4ac7ebc37addb0984659f99f9ba2c98599d88754a4a1bbe5c0fd6c1d458f3297340f98e3f58068ca6e5a2263fa01c8b5441a', NULL, X'789c65905152c3300c44afa20340cf01ffbd80622b44832d656c9902a7ef26244c67fa6959bb6f57d745887355d31e8d43ddc867ea23352e3387d04d6321b1100cc84634dd972aff50933e4a901aad4d92ae1a7f066c9902beb3b7fa6f39c9af73ebf8e0d8d53e813852d02c92d53e28c624fd427485746dbe7a974c55d2c2085749fbb3291be8ddcb980a6a94811ea3be421c8254c9eb5ae41be8b889d82e3f97b6d4dbfba1e919fb941f1b67f7232602bea362cefb1d5e1e0db656e6011ec8f04ba15f9867ca4328fce07f725103e56d2bf07c58d033aed22f7747fd9865');